1 completed, 1 terminated, 1 unknown. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow CUDC 305: new trials by email Literature Review of CUDC 305 trials Research Report on CUDC 305
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of a Novel HSP90 Inhibitor (CUDC-305) in the Treatment of Moderate to Severe Psoriasis. CUDC-305 - Psoriasis Vulgaris | Phase 1 | Unknown | Aarhus University Hospital | 16 | 2018-11-01 | 2019-07-11 |
| A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC] Debio 0932, Cisplatin, Pemetrexed - Non-small Cell Lung Cancer | Phase 1 | Terminated | Debiopharm International SA | 82 | 2012-08-01 | 2015-04-08 |
| Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma Debio 0932 - Cancer, Neoplasms | Phase 1 | Completed | Debiopharm International SA | 81 | 2010-04-01 | 2014-02-03 |
Carcinoma, Non-Small-Cell Lung (1) · Lymphoma (1) · Neoplasms (1)
Debiopharm International SA (2) · Aarhus University Hospital (1)
France (2) · Denmark (1) · Spain (1) · United Kingdom (1)
Enriqueta Felip, PR (1) · Hein van Ingen, M.D. (1) · Jaafar Bennouma, MD (1) · Jean-Pierre Delord, PR (1) · Luis Paz-Ares, PR (1) · Mariano Provencio, PR (1) · Nicolas Isambert, MD (1) · Ruth Plummer, PR (1)
2009 (1)